Incidence and mortality of necrotizing fasciitis in The Netherlands: the impact of group A Streptococcus

Abstract

Background Little is known about the exact incidence of necrotizing soft tissue infections. The few incidences reported in international literature are not directly relatable to the Netherlands, or other European countries, due to geographic heterogeneity in causative micro-organisms involved. This resulted in the aim of this study to map the incidence, mortality rate and hospital course of necrotizing fasciitis infections in the Netherlands to gain insight in the incidence of necrotizing fasciitis in the Netherlands and the associated mortality and health care burden. Methods This nationwide retrospective database study used three distinct data sources to map the incidence of necrotizing fasciitis in the Netherlands between 2014 and 2019, being data from the Dutch Hospital Data (DHD) foundation, data from Osiris-AIZ, which is a database of notifiable diseases managed by regional Public Health Services (GGD) and the National Institute for Public Health and the Environment (RIVM), and previously published studies on necrotizing fasciitis conducted in the Netherlands. Results The incidence of necrotizing fasciitis in the Netherlands is estimated to be approximately 1.1 to 1.4 cases per 100,000 person years, which corresponds to 193–238 patients per year. Of all necrotizing fasciitis infections, 34 to 42% are caused by the group A Streptococcus. Annually, 56 patients die as a result of a necrotizing fasciitis infection (mortality of 23–29%) and 26 patients undergo an amputation for source control (11–14%). Patients stay a mean of 6 to 7 days at the intensive care unit and have a mean hospital length of stay of 24 to 30 days. Conclusion The combination of nationwide databases provides reliable insight in the epidemiology of low-incidence and heterogenic diseases. In the Netherlands, necrotizing fasciitis is a rare disease with group A Streptococcus being the most common causative micro-organism of necrotizing fasciitis. The prior Dutch cohort studies on necrotizing fasciitis report slightly higher sample mortality rates, compared to the population mortality. However, necrotizing fasciitis remain associated with substantial morbidity and mortality, risk at amputation and health care burden characterized by prolonged ICU and hospital stay.

Necrotizing fasciitis: an update on epidemiology, diagnostic methods, and treatment

“…This aligns with global incidence rates typically spanning from 0.86 to 19 cases per 100 000 person-years [5,6]. It's worth noting that European countries such as the Netherlands, tend to have lower prevalence rates (ranging between 1.1 and 1.4 cases per 100 000 person-years) [7]. Conversely, countries with warmer climates like Thailand report rates as high as 32.64 cases per 100 000 person-years [8].…”

A Case of Streptococcal Fasciitis Developing Secondary to Trauma and Progressing with Erythema Multiforme

“…8 NF is still associated with significant morbidity, mortality, amputation risk, prolonged intensive care unit, and hospital stay. 9 To prevent the rapid systemic spread of the infective process, it is very important to perform immediate and comprehensive radical debridement of necrotic tissues together with broad-spectrum intravenous antibiotic therapy. However, due to the lack of specific clinical features in the first stage of the disease, early signs are often confused with cellulitis or abscess, as in our case.…”

A Case Report of Necrotizing Fasciitis of the Neck and Anterior Chest Wall Caused by Odontogenic Infection in Elderly: Diagnosis and Management in Rural Area

“…This format can be used when there is no risk factors. Then the 4 th , 5 th and 6 th decade have a mortality risk 6%, 9% and 14% respectively 16 . When the patient is in a condition of immunocompromised the risk is multiplied by 4.…”